News & Updates

A subcutaneously implanted cardiac monitor device, which incorporates an algorithm designed based on heart rate variability (HRV), may accurately detect focal seizures in individuals with ictal autonomic changes.

New drug applications approved by US FDA as of 16-30 April 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Age-related central arterial stiffness appears to contribute to increased white matter hyperintensity (WMH) volume and decreased total brain volume (TBV), suggests a study. Increased arterial pulsation potentially mediates these associations.

Treatment with bevantolol hydrochloride (SOM3355) is well tolerated and results in a reduction in chorea among patients with Huntington’s disease (HD), a study has shown.

Individuals engaging in more physical activities had lower risks of hospitalization for a multitude of common health conditions, according to a prospective cohort study using data from the UK Biobank.